Rare diseases

Haemophilia treatment for all: A partnership for better access
The WFH Humanitarian Aid Program, supported by Roche, is improving access to haemophilia treatment in developing countries. Learn how the partnership is helping people access diagnosis and prophylactic care
July 09, 2026
How adult SMA patients improve access to care and treatment
Three letters – SMA – tell countless personal stories. Stories of resilience, as adults living with spinal muscular atrophy (SMA) navigate everyday life and overcome challenges to access care and treatment.
November 08, 2024
Series
What makes you, you: Nadya’s story
Nadya doesn’t allow her SMA to define her, as she makes time to pursue her passions such as painting.
August 23, 2024
Addressing urgent gaps in care for adults living with SMA
Adults make up more than half of those living with SMA yet many face significant obstacles in accessing the care and treatment they need
February 29, 2024
Rare within rare: Women with haemophilia
Haemophilia is rare in men – but it’s even more rare in women. Learn more about this gap in haemophilia care, and how it can be addressed.
April 14, 2022
The continuing evolution of clinical trials
Nowadays, clinical trials are highly structured and regulated, ensuring the safety of the participants, but this hasn't always been the case.
January 28, 2022
Roche in complement-mediated diseases
What happens when the complement system, a vital part of the immune system, is not properly regulated? Learn more about complement-mediated diseases.
January 19, 2022
Relapsing multiple sclerosis: Unravelling the maze
Explore how the patient pathway for people living with relapsing MS has changed over the past 20 years.
November 03, 2021
Breaking the rules: The immune system in MS
In people with MS, the body's immune system mistakenly attacks the insulation around nerve cells (myelin) in the brain, spinal cord and optic nerves.
November 03, 2021
Measuring multiple sclerosis (MS) – A glossary
How we define the ways in which multiple sclerosis can be measured.
November 03, 2021
Disease progression in multiple sclerosis
MS disease progression is complicated and not always apparent. Learn what happens to the body in MS and how progression can be measured.
November 03, 2021
NMOSD: Where we have come from, and where we have to go
We are committed to taking an innovative approach to research and development to help preserve what makes people who they are.
November 03, 2021

Explore more

Personalised Healthcare Innovation Data Digital health